U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07495865) titled 'Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2' on March 23.
Brief Summary: Post-market clinical follow-up (PMCF) investigation to evaluate the performance and safety of AnGelHA 2 filler for the correction of moderate to severe wrinkles and folds and facial contour remodeling, in a routine clinical setting.
Study Start Date: Feb. 08
Study Type: OBSERVATIONAL
Condition:
Wrinkles
Recruitment Status: RECRUITING
Sponsor: Glyance
Disclaimer: Curated by HT Syndication....